1. "Melanoma and Immunotherapeutics Service"
Formats
  1. Journal Article (954)
  2. Meeting Abstract (771)
  3. Book Section (42)
  4. Editorial (32)
  5. Review (26)
  6. Research Letter (15)
  7. Guidelines (6)
  8. Correspondence (5)
  9. Conference Paper (4)
  10. Miscellaneous (3)
  11. Book Whole (2)
Groups
  1. Department of Medicine (1860)
  2. Melanoma and Immunotherapeutics Service (1860)
  3. Solid Tumor Oncology Division (1860)
  4. GSK Faculty (1050)
  5. Melanoma Disease Management Team (782)
  6. Hematologic Malignancies, Division of (507)

More Groups

People
  1. Jedd Wolchok (905)
  2. Taha Merghoub (364)
  3. Michael Postow (361)
  4. Paul Chapman (326)
  5. Alexander Shoushtari (244)
  6. Margaret Callahan (197)

More People

Years
  1. 2025 (22)
  2. 2024 (46)
  3. 2023 (66)
  4. 2022 (125)
  5. 2021 (112)
  6. 2020 (122)

More Years

Publications
  1. Journal of Clinical Oncology (330)
  2. Journal for ImmunoTherapy of Cancer (131)
  3. Cancer Research (106)
  4. Clinical Cancer Research (90)
  5. Annals of Oncology (77)
  6. Proceedings of the American Association for Cancer Research Annual Meeting (43)

More Publications

Publishers
  1. American Society of Clinical Oncology (342)
  2. American Association for Cancer Research (274)
  3. Biomed Central Ltd (148)
  4. Elsevier Inc. (144)
  5. Oxford University Press (109)
  6. Nature Publishing Group (88)

More Publishers

Results (1860)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Checkmate 067: A phase III randomized double-blind study of nivolumab (NIVO) monotherapy or NIVO combined with pilimumab (IPI) versus IPI monotherapy in previously untreated patients (PTS) with advanced melanoma (MEL)
    Meeting Abstract

    Wolchok, J. D.; Chiarion-Sileni, V.; Gonzalez, R.; Rutkowski, P.; Grob, J. J.; Cowey, C. L.; Lao, C. D.; Schadendorf, D.; Ferrucci, P. F.; Smylie, M.; more...
    Asia-Pacific Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • A pooled analysis of 655 patients with advanced melanoma enrolled in keynote-001: Long-term efficacy of pembrolizumab (MK-3475)
    Meeting Abstract

    Daud, A.; Joshua, A. M.; Ribas, A.; Robert, C.; Hodi, F. S.; Wolchok, J.; Hwu, W. J.; Weber, J. S.; Gangadhar, T. C.; Joseph, R.; more...
    Asia-Pacific Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Combined nivolumab and ipilimumab or monotherapy in untreated melanoma
    Journal Article

    Larkin, J.; Chiarion-Sileni, V.; Gonzalez, R.; Grob, J. J.; Cowey, C. L.; Lao, C. D.; Schadendorf, D.; Dummer, R.; Smylie, M.; Rutkowski, P.; more...
    New England Journal of Medicine (2015)

    Fulltext@MSK | Save
  • Immune checkpoint blockade in cancer therapy
    Journal Article

    Postow, M. A.; Callahan, M. K.; Wolchok, J. D.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Pooled analysis of long-term survival data from phase II and phase III trials of ipilimumab in unresectable or metastatic melanoma
    Journal Article

    Schadendorf, D.; Hodi, F. S.; Robert, C.; Weber, J. S.; Margolin, K.; Hamid, O.; Patt, D.; Chen, T. T.; Berman, D. M.; Wolchok, J. D.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • A retrospective evaluation of vemurafenib as treatment for BRAF-mutant melanoma brain metastases
    Journal Article

    Harding, J. J.; Catalanotti, F.; Munhoz, R. R.; Cheng, D. T.; Yaqubie, A.; Kelly, N.; McDermott, G. C.; Kersellius, R.; Merghoub, T.; Lacouture, M. E.; more...
    The Oncologist (2015)

    Fulltext@MSK | Save
  • Clinical activity of ipilimumab in acral melanoma: A retrospective review
    Journal Article

    Johnson, D. B.; Peng, C.; Abramson, R. G.; Ye, F.; Zhao, S.; Wolchok, J. D.; Sosman, J. A.; Carvajal, R. D.; Ariyan, C. E.
    The Oncologist (2015)

    Fulltext@MSK | Save
  • Liver resection and ablation for metastatic melanoma: A single center experience
    Journal Article

    Doussot, A.; Nardin, C.; Takaki, H.; Litchman, T. D.; D'Angelica, M. I.; Jarnagin, W. R.; Postow, M. A.; Erinjeri, J. P.; Kingham, T. P.
    Journal of Surgical Oncology (2015)

    Fulltext@MSK | Save
  • Long-term outcome in BRAFV600E melanoma patients treated with vemurafenib: Patterns of disease progression and clinical management of limited progression
    Journal Article

    Puzanov, I.; Amaravadi, R. K.; McArthur, G. A.; Flaherty, K. T.; Chapman, P. B.; Sosman, J. A.; Ribas, A.; Shackleton, M.; Hwu, P.; Chmielowski, B.; more...
    European Journal of Cancer (2015)

    Fulltext@MSK | Save
  • Rapid eradication of a bulky melanoma mass with one dose of immunotherapy
    Journal Article

    Chapman, P. B.; D'Angelo, S. P.; Wolchok, J. D.
    New England Journal of Medicine (2015)

    Fulltext@MSK | Save